Immunomodulation

BIOGRAPHY

Research Interests


It is now well established that cancer patients may acquire tumor specific T- and B-cell immunity. Various types of human tumor cells often express multiple CTL-defined tumor antigens that are shared among tumors, providing the rationale for generic vaccines applicable to large subsets of cancer patients. Our main interests are in understanding the dynamics of tumor antigen-specific T cell responses and applying this knowledge to the design of peptide-based therapeutic vaccines.